Position in TXG
as of Jun 30, 2026
· filed Jul 22, 2026
Position Value
$60,462
+$13,098 QoQ
Shares Held
1,577
-29.3% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#318
of 390 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in TXG Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026SJS Investment Consulting Inc. holds $1,074,047 across 73 Medical Devices names. TXG ranks #6 (5.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
3,030 | $274,941 | |
| 2 | SYK |
Stryker Corp
|
721 | $226,998 | |
| 3 | MDT |
Medtronic plc
|
1,285 | $100,525 | |
| 4 | DXCM |
Dexcom Inc
|
1,025 | $69,033 | |
| 5 | PODD |
Insulet Corp
|
435 | $66,228 | |
| 6 | TXG |
10x Genomics, Inc.
This page
|
1,577 | $60,462 | |
| 7 | STE |
STERIS plc
|
175 | $36,849 | |
| 8 | GMED |
Globus Medical Inc
|
388 | $30,655 |
All Filings in TXG
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $60,462 | 1,577 | Shares | Defined | 2026-07-22 | |
| 2026-03-31 | $47,364 | 2,231 | Shares | Defined | 2026-04-23 | |
| 2025-12-31 | $48,848 | 2,995 | Shares | Sole | 2026-01-21 | |
| No filing history on record for this holder in this stock. | ||||||